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WHEN a serum paraprotein is shown to be a whole immunoglobulin with a
narrow electrophoretic mobility, with heavy chains of only one of the 5 major
classes (G, A, M, D, E) and with light chains of only one of the 2 major classes
(K, L) it is now believed such a monoclonal (M-) immunoglobulin is derived from a
single clone of cells which has developed from a single cell. This is largely due
to the concepts of Waldenstrom and Burnet and the fundamental analysis of
immunoglobulin structure of Porter and others, reviewed by Hobbs (1966).
The monoclonal hypothesis derives experimental support from the model of
mouse plasmacytoma developed by Potter for Osserman, Rifkind, Takatsuki and
Lawlor (1964) showed that for up to 88 passages of relatively small numbers of
tumour cells (as low as 1000) the plasmacytoma line bred true and continued to
secrete the same M-protein as was found initially. We are unaware of the final
proofoftransferby asingle plasmacytoma cell andhave ourselves beenunsuccessful
in the attempt. Kunkel (1963-64) pointed out that the frequency ofthe 2 classes
of light chain (670% K, 330% L) was the same among the normal polyclonal and
the monoclonal immunoglobulins and suggested that the abnormal monoclones
developed at random from the normal polyclonal population. The object of this
paper is to complete the evidence with heavy chain classification.
METHODS
Frequency observed for M-immunoglobulin8
As a reference centre especially for the Medical Research Council Myeloma
Trial, we have collected material from 438 consecutive patients in whom M-proteins
were confirmed by methods previously described (Hobbs, 1967). This excludes
selected cases referred as problems. In 378 patients the M-components were
identified as whole immunoglobulins and classed as in Table I.
In 52 patients only monoclonal light chains (Bence-Jones proteins) were found
and incidentally 35 (67%) were Type K and 17 (330%) were Type L. In the
remaining eight patients more than one M-protein was found: testing showed the
inclusion of their whole immunoglobulin data would not significantly alter the
percentages in Table I. Datafrom the above 60 patients is not included in Table I
in order to keep it as simple as possible.
Frequency derived for normal immunoglobulins
From turnover studies in normal subjects it can be calculated that a 70 kg.
man would synthesis daily 2-52 g. ofyG-globulin (36 mg./kg.: Solomon, Waldmanil
and Fahey, 1963), 0 48 g. ofyM-globulin (6-9 mg./kg.: Barth, Wochner, WaldmannJ. R. HOBBS
and Fahey, 1964) and 0 03 g. of yD-globulin (0.4 mg./kg.: Rogentine, Rowe,
Bradley, Waldmann and Fahey, 1966). Estimates for the normal synthetic
rate ofyA-globulin vary from 9 mg./kg. (Gitlin, 1967) to 30 mg./kg. (Solomon and
Tomasi, 1964); using 20 mg./kg. would make it 1-4 g. daily. The turnover of
yE-globulin is unknown but is probably very little and only one monoclonal
yE-protein has been found to date (Johansson and Bennich, 1967). For each
class (except E) these values have been expressed in Table I as a percentage ofthe
daily total production of 4-43 g. of immunoglobulins. Since all immunoglobulin
forming cells so far measured produce immunoglobulin at about the same rate
(Nossal and Makela, 1962) the daily production for each class could represent the
proportion of normal cells of that class present within the body.
RESULTS
If the daily production of each class ofimmunoglobulin truly reflects the num-
bers of cells synthesising each class then their incidence is very similar to that of
M-immunoglobulins (Table I). There are small discrepancies for G and A classes.
TA-BLE I. Incidence of 378 Consecutive Monoclonal Components Recognisable as
Whole Immunoglobulins Compared to the Daily Production of Nlormal
Immunoglobutlins
Heavy chain class Light chain class
G A M D K L
% Normal total 57 31 11 1 67 33
% M-immunoglobuliins 63 25 11 1 66 34
Because yG M-proteins have longer half-lives (7-35 days) they achieve a high
serum level (average 4 3 g./100 ml. at presentation). The half-lives of yA
M-proteins are shorter (5-8 days) and their presenting levels lower (average
2-8 g./100 ml.). It follows yG M-proteins are likely to be more readily detected
than yA M-proteins and this may explain the small discrepancies.
DISCUSSION
The results in Table I support the hypothesis that the change from a normal
antibody-forming cell to one which continues to proliferate in a neoplastic manner
to form a monoclone occurs randomly among all the antibody-forming cells.
The heavy chain class data add more weight to the original observations ofKunkel
based solely on light chain data.
The occurrence and fate of the monoclones among natural (Hallen, 1966) and
hospital (Hobbs, 1967; for yM see Hobbs, 1968) populations have been reviewed
elsewhere. The present data are derived from hospital populations where some
60%O of the monoclones become recognisable as malignant neoplasms of the
reticulo-endothelial system.
The above hypothesis however is difficult to apply to the secretory yA system
(Tomasi, Tan, Solomon and Prendergast, 1965). There is a growing interest in
cells secreting yA-globulin, which for example can be found in very large numbers
in the lamina propria of the small intestine (Crabbe, Carbonaro and Heremans,
1965). Yet yA-plasmacytoma of the gut is a great rarity in our experience: we
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have seen only one case. Either the cells of the lamina propria rarely mutate to
monoclone formation in situ, or have to emigrate to the bone marrow to proliferate.
Their product is in dispute. Secretory yA-globulin is found in secretions
probably in the form of a dimer of 2 7S-units (mol. wt. 160,000) together with
probably 2 secretory or T-pieces (mol. wt. 20,000) and has a mol. wt. 360,000
(11S). Some, including the author, believe the plasma cells of the lamina propria
secrete a 7S yA-globulin which is then taken up by the epithelial cells of the gut,
where it is dimerised and T-piece is added before its one way secretion into the
lumen. Others, (Rossen, Morgan, Hsu, Butler and Rose, 1968) think the plasma
cells secrete both yA-globulin and T-piece. A personal search among over 100
yA M-proteins has not revealed any existing in the form of secretory yA-globulin
and in this we are in agreement with Ballieux, Stoop and Zegers, (1968). Thus
either this system ofyA-antibody forming cells is unique and never forms mono-
clones, or if it does such monoclones now regularly fail to form T-piece or Rossen
et al. may be mistaken. In any event it has to be admitted that secretory yA
cells do not form recognisable monoclones in situ in accord with the numbers of
cells at risk.
SUMMARY
Further evidence is provided to support the hypothesis that monoclone forma-
tion occurs in arandom manner among cells capable ofproducing immunoglobulins.
Reservations are made with regard to the secretory yA system.
This paper has largely been a product ofthe teamwork ofthe M.R.C. myeloma
trial, whose 14 centres are listed elsewhere (Hobbs, 1969). I am also indebted
for the personal assistance of Dr. A. A. Corbett, Miss Felicity Henderson, Mrs.
Urmila Patel and Mrs. Ann Kasler, and the encouragement of Professors I. D. P.
Wootton, J. V. Dacie and Dr. D. Galton.
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